Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CISD1 | Q9NZ45 | 6/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | PNLIP | P16233 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11311346 | 0.81 | ALDH1A1 (0.43) | KDM4EALDH1A1POLBTHRBRECQL | |
| SCHEMBL14139915 | 0.78 | HRH3 (0.52) | — | |
| SCHEMBL6532561 | 0.77 | CNR2 (0.56) | KDM4EALDH1A1L3MBTL1 | |
| SCHEMBL9194517 | 0.76 | ABL1 (0.47) | CISD1KDM4E | |
| SCHEMBL15635741 | 0.76 | KDM4E (0.63) | CISD1KDM4EALDH1A1POLBTHRB | |
| SCHEMBL7549269 | 0.76 | ABL1 (0.44) | CISD1KDM4EALDH1A1EPHX1 | |
| SCHEMBL12513577 | 0.76 | CXCR4 (0.46) | KDM4EALDH1A1 | |
| SCHEMBL28655003 | 0.75 | KDM4E (0.53) | CISD1KDM4EALDH1A1POLB | |
| SCHEMBL12513692 | 0.75 | LMNA (0.55) | ALDH1A1L3MBTL1 | |
| SCHEMBL12513580 | 0.74 | GAA (0.52) | KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109195599-B | Antifungal composition | 株式会社种探索研究所 | 2023-02-03 | — | — | CN | disclosed |
| EP-3960172-A1 | ANTIFUNGAL COMPOSITION | Seed Research Institute Co., Ltd. (JP) | 2022-03-02 | — | — | EP | disclosed |
| US-10980813-B2 | Antifungal composition | SEED RESEARCH INSTITUTE CO., LTD. (JP) | 2021-04-20 | — | — | US | disclosed |
| US-20190216820-A1 | ANTIFUNGAL COMPOSITION | SEED RESEARCH INSTITUTE CO., LTD. (JP) | 2019-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190216820-A1 | ANTIFUNGAL COMPOSITION | ERG28, NR2E1, NR2C2 | CISD1 2044/4885KDM4E 3754/4885ALDH1A1 4071/4885 |
| US-10980813-B2 | Antifungal composition | ERG28, NR2E1, NR2C2 | CISD1 2044/4885KDM4E 3754/4885ALDH1A1 4071/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.